|By PR Newswire||
|August 5, 2014 05:15 AM EDT||
EATONTOWN, N.J., Aug. 5, 2014 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") has signed an Exclusive Development, Supply & Distribution Agreement with Dexcel Ltd. ("Dexcel") for an Extended Release ANDA drug product. Dexcel will be responsible for the development, registration and manufacturing of the product, and Heritage Pharmaceuticals will be responsible for marketing and distribution in the U.S. The product generates generic annual U.S. sales of approximately $60 million, per IMS Health. Financial terms of the agreement were not disclosed.
Jeffrey A. Glazer, Heritage's Vice Chairman and CEO stated, "I am pleased to expand our relationship with Dexcel for high barrier, technology driven pharmaceutical products. This agreement builds upon our platform of pipeline expansion through strategic alliance and will complement our organic product assets as we continue to offer a broad portfolio of value driven medicine to the U.S. consumer."
Heritage Pharmaceuticals Inc. is a specialty pharmaceutical company engaged in the development, manufacturing, sales and marketing of generic and legacy branded pharmaceutical products for the U.S. prescription drug market. Since inception, our customers have experienced the benefits of our continuous product expansion and global alliance network that has produced an impressive portfolio of over 150 products spanning multiple dosage forms. Heritage's products cover a number of therapeutic categories, including but not limited to: oncology, cardiovascular, metabolic disease, anti-infective and pain management. Whether its oral solids or complex injectables, the Heritage portfolio is poised to continue to rapidly expand and deliver the Value Driven Medicine required to keep our customers competitive in the marketplace.
About Dexcel Pharma
Dexcel Pharma is a private international specialty pharmaceutical group, dedicated to the development, manufacturing and commercialization of novel drug formulations and complex generics. Dexcel Pharma has a broad portfolio of branded and generic products, sold in more than 30 countries worldwide. Dexcel Pharma was established in 1968 and is headquartered in Israel.
SOURCE Heritage Pharmaceuticals Inc.
Jul. 30, 2016 05:15 AM EDT Reads: 2,701
Jul. 30, 2016 05:15 AM EDT Reads: 1,460
Jul. 30, 2016 04:45 AM EDT Reads: 1,462
Jul. 30, 2016 04:00 AM EDT Reads: 2,122
Jul. 30, 2016 03:00 AM EDT Reads: 1,642
Jul. 30, 2016 02:45 AM EDT Reads: 1,488
Jul. 30, 2016 02:15 AM EDT Reads: 1,186
Jul. 30, 2016 02:00 AM EDT Reads: 1,688
Jul. 30, 2016 12:30 AM EDT Reads: 2,133
Jul. 30, 2016 12:30 AM EDT Reads: 2,345
Jul. 29, 2016 10:15 PM EDT Reads: 2,079
Jul. 29, 2016 10:00 PM EDT Reads: 1,292
Jul. 29, 2016 09:45 PM EDT Reads: 1,506
Jul. 29, 2016 08:00 PM EDT Reads: 2,749
We all know the latest numbers: Gartner, Inc. forecasts that 6.4 billion connected things will be in use worldwide in 2016, up 30 percent from last year, and will reach 20.8 billion by 2020. We're rapidly approaching a data production of 40 zettabytes a day – more than we can every physically store, and exabytes and yottabytes are just around the corner. For many that’s a good sign, as data has been proven to equal money – IF it’s ingested, integrated, and analyzed fast enough. Without real-ti...
Jul. 29, 2016 07:45 PM EDT Reads: 1,193